Phaarmasia

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE486I01016
  • NSEID:
  • BSEID: 523620
INR
100.47
7.77 (8.38%)
BSENSE

Nov 20

BSE+NSE Vol: 3.34 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 306122,
    "name": "Phaarmasia",
    "stock_name": "Phaarmasia",
    "full_name": "Phaarmasia Ltd",
    "name_url": "stocks-analysis/phaarmasia",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "100.47",
    "chg": 7.77,
    "chgp": "8.38%",
    "dir": 1,
    "prev_price": "92.70",
    "mcapval": "69.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 523620,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE486I01016",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "3.34 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/phaarmasia-306122-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Phaarmasia Ltd Valuation Shifts Signal Elevated Risk Amid Price Correction",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/phaarmasia-ltd-valuation-shifts-signal-elevated-risk-amid-price-correction-4262902",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/PhaarmasiaLtd_valuationdot_4262902.png",
        "date": "2026-11-16 08:00:28",
        "description": "Phaarmasia Ltd has witnessed a marked deterioration in its valuation parameters, shifting from a previously attractive profile to one now classified as risky. This change accompanies a sharp 7.85% drop in the stock price, reflecting growing investor concerns amid stretched price-to-earnings and price-to-book multiples compared to both historical levels and peer averages."
      },
      {
        "title": "Phaarmasia Ltd Falls 3.35%: Key Financial Setbacks and Volatility Mark the Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/phaarmasia-ltd-falls-335-key-financial-setbacks-and-volatility-mark-the-week-4262282",
        "imagepath": "",
        "date": "2026-11-15 10:00:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 09:</strong> Stock declines 2.99% to Rs.79.55 despite Sensex rising 0.48%</p>\n                    <p><strong>Nov 11:</strong> Sharp rebound with 8.11% gain to Rs.86.00, outpacing Sensex’s 0.92% rise</p>\n                    <p><strong>Nov 12:</strong> Stock holds steady at Rs.86.00 while Sensex gains 0.32%</p>\n                    <p><strong>Nov 13:</strong> Stock plunges 7.85% to Rs.79.25 amid negative financial news; Sensex falls 0.46%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.82.00</div></div>\n                    <div class=\"stat-item\"><div cl..."
      },
      {
        "title": "Phaarmasia Ltd Reports Negative Financial Trend Amidst Volatile Market Performance",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/phaarmasia-ltd-reports-negative-financial-trend-amidst-volatile-market-performance-4260829",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/PhaarmasiaLtd_fintrenddot_4260829.png",
        "date": "2026-11-13 11:00:31",
        "description": "Phaarmasia Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a marked deterioration in its financial trend during the September 2026 quarter. Despite a recent surge in its share price, the company’s latest quarterly results reveal declining profitability and contracting revenues, signalling challenges ahead for investors amid a volatile market backdrop."
      },
      {
        "title": "Phaarmasia Ltd is Rated Sell by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/phaarmasia-ltd-is-rated-sell-by-marketsmojo-4240546",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/PhaarmasiaLtd_mojoScore_4240546.png",
        "date": "2026-10-27 10:11:20",
        "description": "Phaarmasia Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 October 2026, providing investors with the most recent and relevant data to assess the company’s outlook."
      },
      {
        "title": "Phaarmasia Ltd is Rated Sell by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/phaarmasia-ltd-is-rated-sell-by-marketsmojo-4225322",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/PhaarmasiaLtd_mojoScore_4225322.png",
        "date": "2026-10-14 10:11:07",
        "description": "Phaarmasia Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Phaarmasia Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/phaarmasia-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-sector-challenges-4213529",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/PhaarmasiaLtd_valuationdot_4213529.png",
        "date": "2026-10-05 08:00:46",
        "description": "Phaarmasia Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a very attractive price range, despite ongoing sector headwinds. This revaluation, driven by improved price-to-earnings and price-to-book ratios relative to peers and historical averages, offers investors a fresh perspective on the micro-cap pharmaceutical player’s market positioning and potential."
      },
      {
        "title": "Phaarmasia Ltd Upgraded to Sell on Improved Technicals and Valuation",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/phaarmasia-ltd-upgraded-to-sell-on-improved-technicals-and-valuation-4211712",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/PhaarmasiaLtd_mojoScore_4211712.png",
        "date": "2026-10-02 08:04:55",
        "description": "Phaarmasia Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 October 2026, reflecting notable improvements in its technical outlook and valuation metrics despite ongoing challenges in financial performance. The micro-cap pharmaceutical company’s Mojo Score rose to 47.0, signalling a cautious but more optimistic stance among analysts."
      },
      {
        "title": "Phaarmasia Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/phaarmasia-ltd-is-rated-strong-sell-4208522",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/PhaarmasiaLtd_mojoScore_4208522.png",
        "date": "2026-09-29 10:10:03",
        "description": "Phaarmasia Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 04 September 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 29 September 2026, providing investors with the most recent and relevant data to assess the stock’s outlook."
      },
      {
        "title": "Phaarmasia Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/phaarmasia-ltd-is-rated-strong-sell-4197379",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/PhaarmasiaLtd_mojoScore_4197379.png",
        "date": "2026-09-18 10:10:03",
        "description": "Phaarmasia Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 04 September 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 52,
    "sid": "306122",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/phaarmasia-306122"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Nov-2026",
      "details": "Newspaper Advertisement of the Unaudited Financial Results for the Quarter ended 30th september 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday 12Th November 2026 Held Through Video Conference",
      "datetime": "12-Nov-2026",
      "details": "",
      "source": "BSE"
    },
    {
      "caption": "Financial Results For The Quarter Ended 30Th September 2026 - Regulation 33(3)(A) Of SEBI (LODR) Regulations 2015",
      "datetime": "12-Nov-2026",
      "details": "Financial Results for the Quarter ended 30th september 2026 along with Limited Review Report",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

14-Nov-2026 | Source : BSE

Newspaper Advertisement of the Unaudited Financial Results for the Quarter ended 30th september 2026

Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday 12Th November 2026 Held Through Video Conference

12-Nov-2026 | Source : BSE

Financial Results For The Quarter Ended 30Th September 2026 - Regulation 33(3)(A) Of SEBI (LODR) Regulations 2015

12-Nov-2026 | Source : BSE

Financial Results for the Quarter ended 30th september 2026 along with Limited Review Report

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available